Drug prices · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Drug expenditure · Norwegian citizens taking one of the following drugs: citalopram (depression), omeprazol (antiulcer), cetirizin (allergy), loratadin…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Death or major disability by 18 to 24 months corrected age (aligned definition) · extremely preterm infants
The intervention showed no clear difference in death or major disability by 18 to 24 months corrected age (aligned… (high certainty).
1 finding from 1 review
Intervention not reported
Death to 18 to 24 months corrected age · extremely preterm infants
The intervention leads to higher death to 18 to 24 months corrected age (high certainty).
1 finding from 1 review
Intervention not reported
Major disability by 18 to 24 months corrected age (aligned definition) · extremely preterm infants
The intervention showed no clear difference in major disability by 18 to 24 months corrected age (aligned definition) (high certainty).
1 finding from 1 review
Intervention not reported
Retinopathy of prematurity requiring treatment · extremely preterm infants
The intervention probably leads to lower retinopathy of prematurity requiring treatment (moderate certainty).
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis · extremely preterm infants
The intervention leads to higher necrotising enterocolitis (high certainty).
1 finding from 1 review
Intervention not reported
Blindness · extremely preterm infants
The intervention showed no clear difference in blindness (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality within the longest · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in mortality within the longest (low certainty).
1 finding from 1 review
Intervention not reported
Mortality within the longest · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
It is very uncertain whether the intervention changes mortality within the longest (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
1 finding from 1 review
Intervention not reported
Mortality within 30 days of · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
1 finding from 1 review
Intervention not reported
Surgical site infection within 30 days in trials with low risk of bias (14 days to 30 days) · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in surgical site infection within 30 days in trials with low risk of… (low certainty).
1 finding from 1 review
Intervention not reported
Surgical site infection within 30 days, irrespective of risk of bias (14 days to 30 days) · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in surgical site infection within 30 days, irrespective of risk of bias… (low certainty).
1 finding from 1 review
Intervention not reported
Respiratory insufficiency · surgical patients with need for abdominal, caesarean section, orthopaedic or breast surgery
The intervention showed no clear difference in respiratory insufficiency (moderate certainty).
1 finding from 1 review